Riggs Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Riggs Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$908	–	506
2025 Q2	$908	Hold	1,000	–	–	﹤0.01%	780
2025 Q1	$452	Hold	1,000	–	–	﹤0.01%	572
2024 Q4	$496	Hold	1,000	–	–	﹤0.01%	547
2024 Q3	$906	Sell	1,000 -8,600	-90%	-$7.97K	﹤0.01%	455
2024 Q2	$9.57K	Hold	9,600	–	–	﹤0.01%	253
2024 Q1	$14.2K	Hold	9,600	–	–	﹤0.01%	223
2023 Q4	$10.5K	Sell	9,600 -1,000	-9%	-$1.09K	﹤0.01%	243
2023 Q3	$12.5K	Hold	10,600	–	–	﹤0.01%	226
2023 Q2	$14.9K	Hold	10,600	–	–	0.01%	213
2023 Q1	$15.9K	Hold	10,600	–	–	0.01%	196
2022 Q4	$12.4K	Hold	10,600	–	–	0.01%	199
2022 Q3	$12K	Hold	10,600	–	–	﹤0.01%	206
2022 Q2	$17K	Hold	10,600	–	–	0.01%	184
2022 Q1	$16K	Hold	10,600	–	–	﹤0.01%	210
2021 Q4	$26K	Hold	10,600	–	–	0.01%	194
2021 Q3	$27K	Hold	10,600	–	–	0.01%	179
2021 Q2	$30K	Hold	10,600	–	–	0.01%	177
2021 Q1	$25K	Hold	10,600	–	–	0.01%	178
2020 Q4	$19K	Buy	+10,600	New	+$14.8K	0.01%	178
2020 Q3	–	Sell	-11,600	Closed	-$10K	–	207
2020 Q2	$10K	Hold	11,600	–	–	﹤0.01%	172
2020 Q1	$9K	Hold	11,600	–	–	0.01%	172
2019 Q4	$10K	Hold	11,600	–	–	﹤0.01%	205
2019 Q3	$11K	Hold	11,600	–	–	0.01%	176
2019 Q2	$13K	Hold	11,600	–	–	0.01%	173
2019 Q1	$15K	Hold	11,600	–	–	0.01%	161
2018 Q4	$11K	Sell	11,600 -3,373	-23%	-$5.17K	0.01%	155
2018 Q3	$30K	Hold	14,973	–	–	0.01%	131
2018 Q2	$27K	Sell	14,973 -458	-3%	-$922	0.01%	140
2018 Q1	$36K	Buy	15,431 +458	+3%	+$1.07K	0.01%	136
2017 Q4	$28K	Hold	14,973	–	–	0.01%	150
2017 Q3	$37K	Hold	14,973	–	–	0.02%	137
2017 Q2	$41K	Buy	14,973 +4,572	+44%	+$12.8K	0.02%	144
2017 Q1	$31K	Buy	10,401 +1,143	+12%	+$3.25K	0.02%	142
2016 Q4	$29K	Hold	9,258	–	–	0.01%	140
2016 Q3	$32K	Buy	+9,258	New	+$25.6K	0.02%	135